Re-evaluation of glycated hemoglobin and glycated albumin with continuous glucose monitoring system as markers of glycemia in patients with liver cirrhosis Retraction in /10.3892/br.2017.928

Isoda,Hiroshi; Takahashi,Hirokazu; Eguchi,Yuichiro; Kojima,Motoyasu; Inoue,Kanako; Murayama,Kenichiro; Matsuda,Yayoi; Anzai,Keizo

doi:10.3892/br.2016.808

Re-evaluation of glycated hemoglobin and glycated albumin with continuous glucose monitoring system as markers of glycemia in patients with liver cirrhosis

Retraction in: /10.3892/br.2017.928

Authors:
- Hiroshi Isoda
- Hirokazu Takahashi
- Yuichiro Eguchi
- Motoyasu Kojima
- Kanako Inoue
- Kenichiro Murayama
- Yayoi Matsuda
- Keizo Anzai
View Affiliations

Affiliations: Division of Metabolism and Endocrinology, Faculty of Medicine, Saga University, Saga 8498501, Japan, Division of Hepatology, Liver Center, Saga Medical School, Saga 8498501, Japan
Published online on: November 10, 2016 https://doi.org/10.3892/br.2016.808
Pages: 51-56
Copyright: © Isoda et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Liver cirrhosis (LC) is frequently accompanied by glucose intolerance. The present study was designed to determine whether glycated hemoglobin A1c (HbA1c) and glycated albumin (GA) were predictive markers of glycemia, as determined by a continuous glucose monitoring system (CGMS), in patients with LC. A total of 30 patients with LC, including 3, 19, 5, 2 and 1 with LC due to hepatitis B virus, hepatitis C virus, non‑alcoholic steatohepatitis, alcohol and unknown causes, respectively, were assessed by CGMS. The average, maximum and minimum blood glucose (BG) levels were measured by CGMS, and correlated with HbA1c and GA. The average, maximum and minimum BG in these individuals were 142±38.7, 209.3±65.7 and 85.1±25.4 mg/dl, respectively. HbA1c was significantly correlated with average BG (r=0.447, P=0.015) and maximum BG (r=0.523, P=0.004). In addition, GA was significantly correlated with average BG (r=0.687, P<0.001) and maximum BG (r=0.648, P<0.001). Neither HbA1c nor GA was significantly correlated with minimum BG. Correlation analysis yielded formulas by which HbA1c and GA were predictive of average BG in individuals with LC: Average BG=19.2 x HbA1c (%) + 36.5 and average BG=6.6 x GA (%) + 13.0, respectively. In conclusion, HbA1c and GA showed significant correlations with average and maximum BG, as determined by CGMS. The derived formulas allow for estimates of average BG based on HbA1c and GA, and may contribute to the control of glycemia in patients with LC.

View Figures

View References

1	Kruszynska YT, Home PD and McIntyre N: Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology. 14:103–111. 1991. View Article : Google Scholar : PubMed/NCBI
2	Megyesi C, Samols E and Marks V: Glucose tolerance and diabetes in chronic liver disease. Lancet. 2:1051–1056. 1967. View Article : Google Scholar : PubMed/NCBI
3	Gillett MJ: International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 2009; 32(7): 1327–1334. Clin Biochem Rev. 30:197–200. 2009.PubMed/NCBI
4	Seino Y, Nanjo K, Tajima N, Kadowaki T, Kashiwagi A, Araki E, Ito C, Inagaki N, Iwamoto Y, Kasuga M, et al: Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus: Report of the committee on the classification and diagnostic criteria of diabetes mellitus. J Diabetes Investig. 1:212–228. 2010. View Article : Google Scholar : PubMed/NCBI
5	Garlick RL and Mazer JS: The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem. 258:6142–6146. 1983.PubMed/NCBI
6	Day JF, Ingebretsen CG, Ingebretsen WR Jr, Baynes JW and Thorpe SR: Nonenzymatic glucosylation of serum proteins and hemoglobin: Response to changes in blood glucose levels in diabetic rats. Diabetes. 29:524–527. 1980. View Article : Google Scholar : PubMed/NCBI
7	Koga M, Kasayama S, Kanehara H and Bando Y: CLD (chronic liver diseases)-HbA1C as a suitable indicator for estimation of mean plasma glucose in patients with chronic liver diseases. Diabetes Res Clin Pract. 81:258–262. 2008. View Article : Google Scholar : PubMed/NCBI
8	Sterling K: The turnover rate of serum albumin in man as measured by I131-tagged albumin. J Clin Invest. 30:1228–1237. 1951. View Article : Google Scholar : PubMed/NCBI
9	Boyne MS, Silver DM, Kaplan J and Saudek CD: Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes. 52:2790–2794. 2003. View Article : Google Scholar : PubMed/NCBI
10	Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D and Heine RJ: Alc-Derived Average Glucose Study Group: Translating the A1C assay into estimated average glucose values. Diabetes Care. 31:1473–1478. 2008. View Article : Google Scholar : PubMed/NCBI
11	Bedossa P: The French METAVIR Cooperative Study Group: Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 20:15–20. 1994. View Article : Google Scholar : PubMed/NCBI
12	Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA and Bacon BR: Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol. 94:2467–2474. 1999. View Article : Google Scholar : PubMed/NCBI
13	Inoue K, Tsujimoto T, Yamamoto-Honda R, Goto A, Kishimoto M, Noto H, Kajio H, Doi S, Miyazaki S, Terauchi Y, et al: A newer conversion equation for the correlation between HbA1c and glycated albumin. Endocr J. 61:553–560. 2014. View Article : Google Scholar : PubMed/NCBI
14	Kanda Y: Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 48:452–458. 2013. View Article : Google Scholar : PubMed/NCBI
15	Petersen KF, Krssak M, Navarro V, Chandramouli V, Hundal R, Schumann WC, Landau BR and Shulman GI: Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis. Am J Physiol. 276:E529–E535. 1999.PubMed/NCBI
16	Tajika M, Kato M, Mohri H, Miwa Y, Kato T, Ohnishi H and Moriwaki H: Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition. 18:229–234. 2002. View Article : Google Scholar : PubMed/NCBI
17	Imano E, Kanda T, Nakatani Y, Motomura M, Arai K, Matsuhisa M, Yamasaki Y and Hori M: Impaired splanchnic and peripheral glucose uptake in liver cirrhosis. J Hepatol. 31:469–473. 1999. View Article : Google Scholar : PubMed/NCBI
18	Nielsen MF, Caumo A, Aagaard NK, Chandramouli V, Schumann WC, Landau BR, Schmitz O and Vilstrup H: Contribution of defects in glucose uptake to carbohydrate intolerance in liver cirrhosis: Assessment during physiological glucose and insulin concentrations. Am J Physiol Gastrointest Liver Physiol. 288:G1135–G1143. 2005. View Article : Google Scholar : PubMed/NCBI
19	Petrides AS, Stanley T, Matthews DE, Vogt C, Bush AJ and Lambeth H: Insulin resistance in cirrhosis: Prolonged reduction of hyperinsulinemia normalizes insulin sensitivity. Hepatology. 28:141–149. 1998. View Article : Google Scholar : PubMed/NCBI
20	Cusin I, Terrettaz J, Rohner-Jeanrenaud F and Jeanrenaud B: Metabolic consequences of hyperinsulinaemia imposed on normal rats on glucose handling by white adipose tissue, muscles and liver. Biochem J. 267:99–103. 1990. View Article : Google Scholar : PubMed/NCBI
21	Heaton JH and Gelehrter TD: Desensitization of hepatoma cells to insulin action. Evidence for a post-receptor mechanism. J Biol Chem. 256:12257–12262. 1981.PubMed/NCBI
22	Wardzala LJ, Hirshman M, Pofcher E, Horton ED, Mead PM, Cushman SW and Horton ES: Regulation of glucose utilization in adipose cells and muscle after long-term experimental hyperinsulinemia in rats. J Clin Invest. 76:460–469. 1985. View Article : Google Scholar : PubMed/NCBI
23	Bianchi G, Marchesini G, Zoli M, Bugianesi E, Fabbri A and Pisi E: Prognostic significance of diabetes in patients with cirrhosis. Hepatology. 20:119–125. 1994. View Article : Google Scholar : PubMed/NCBI
24	Nishida T, Tsuji S, Tsujii M, Arimitsu S, Haruna Y, Imano E, Suzuki M, Kanda T, Kawano S, Hiramatsu N, et al: Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis. Am J Gastroenterol. 101:70–75. 2006. View Article : Google Scholar : PubMed/NCBI
25	Moreau R, Delègue P, Pessione F, Hillaire S, Durand F, Lebrec D and Valla DC: Clinical characteristics and outcome of patients with cirrhosis and refractory ascites. Liver Int. 24:457–464. 2004. View Article : Google Scholar : PubMed/NCBI
26	Jepsen P, Watson H, Andersen PK and Vilstrup H: Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients. J Hepatol. 63:1133–1138. 2015. View Article : Google Scholar : PubMed/NCBI
27	Wlazlo N, van Greevenbroek MM, Curvers J, Schoon EJ, Friederich P, Twisk JW, Bravenboer B and Stehouwer CD: Diabetes mellitus at the time of diagnosis of cirrhosis is associated with higher incidence of spontaneous bacterial peritonitis, but not with increased mortality. Clin Sci (Lond). 125:341–348. 2013. View Article : Google Scholar : PubMed/NCBI
28	Ariza X, Castellote J, Lora-Tamayo J, Girbau A, Salord S, Rota R, Ariza J and Xiol X: Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis. J Hepatol. 56:825–832. 2012. View Article : Google Scholar : PubMed/NCBI
29	Cheruvattath R and Balan V: Infections in patients with end-stage liver disease. J Clin Gastroenterol. 41:403–411. 2007. View Article : Google Scholar : PubMed/NCBI
30	Kawaguchi T, Itou M, Taniguchi E, Sakata M, Abe M, Koga H, Oriishi T, Imamura Y, Kato T, Yamada K, et al: Serum level of free fatty acids is associated with nocturnal hypoglycemia in cirrhotic patients with HCV infection: A pilot study. Hepatogastroenterology. 58:103–108. 2011.PubMed/NCBI
31	Hashiba M, Ono M, Hyogo H, Ikeda Y, Masuda K, Yoshioka R, Ishikawa Y, Nagata Y, Munekage K, Ochi T, et al: Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease. PLoS One. 8:e761612013. View Article : Google Scholar : PubMed/NCBI
32	Kishimoto M and Noda M: Verification of glycemic profiles using continuous glucose monitoring: Cases with steroid use, liver cirrhosis, enteral nutrition, or late dumping syndrome. J Med Invest. 62:1–10. 2015. View Article : Google Scholar : PubMed/NCBI